China's LAA closure devices market to grow at 5% CAGR through 2033 | Healthcare Asia Magazine
, China
Photo from Envato

China's LAA closure devices market to grow at 5% CAGR through 2033

The competitive landscape is expected to fuel an increase in research and development investments.

China’s left atrial appendage (LAA) closure devices market is projected to rise at a compound annual growth rate (CAGR) of 5% through 2033, on the back of a rising prevalence of atrial fibrillation (AFib) and increased stroke prevention awareness, said GlobalData.

A recent key development is the regulatory approval of AtriCure's AtriClip system by the country’s National Medical Products Administration (NMPA).

According to the report, AtriCure holds a 35% share of the Asia Pacific (APAC) structural heart occlusion device market.

Jyoti Sharma, medical devices analyst at GlobalData, said that this is likely to encourage competitors to enhance their product offerings and strategies.

“This competitive landscape is expected to drive increased investment in research and development,” she said.

 

Follow the link s for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!